This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
What the researchers found
Molecular docking showed angiotensin receptor blockers bind to opioid and adrenergic receptors with higher affinity than their native ligands, suggesting potential therapeutic applications in addiction and hypertension.
Why it matters
If blood pressure drugs can block opioid receptors, they might help treat opioid addiction. This computational finding needs laboratory confirmation but could repurpose existing medications.
The numbers in context
ARBs showed higher binding affinity for mu- and delta-opioid receptors than fentanyl and naltrexone. ARBs partially reduced (20-50%) contractile responses to phenylephrine at very low concentrations. MD simulations stable over nanosecond timescales.
How the study worked
Virtual ligand screening (docking) and molecular dynamics simulations for ARBs, opioids, and adrenergic ligands at AT1R, alpha-1AR, alpha-2AR, mu-opioid, and delta-opioid receptors.
Who was studied
Computer models of G-protein coupled receptors
What this study cannot tell us
Entirely computational. Binding affinity predictions need experimental confirmation. In silico docking scores do not guarantee functional effects. No in vivo or clinical data.
Read the original research
Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction.
Biomolecules, 15(6)
Citation
Ridgway, Harry; Moore, Graham J; Gadanec, Laura Kate; Matsoukas, John M. (2025). Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction.. Biomolecules, 15(6). https://doi.org/10.3390/biom15060855